Non Small Cell Lung Cancer

Showing NaN - NaN of 51

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in Canada, United States (EDP1503,

Completed
  • Colorectal Cancer Metastatic
  • +6 more
  • EDP1503
  • Pembrolizumab
  • Rogers, Arkansas
  • +7 more
Nov 11, 2021

Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • GRT-C901
  • +3 more
  • Phoenix, Arizona
  • +10 more
Aug 31, 2021

Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Pembrolizumab)

Terminated
  • Non Small Cell Lung Cancer
  • Huntsville, Alabama
  • +73 more
Jan 15, 2021

Non Small Cell Lung Cancer Trial in Worldwide (RAD001, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Atlanta, Georgia
  • +13 more
Dec 17, 2020

Circulating Tumor DNA From LIquid Biopsy in Early Stage NSCLC

Terminated
  • Non Small Cell Lung Cancer
  • biospecimen collection
  • Atlanta, Georgia
  • +5 more
Nov 18, 2020

A Study of Personalized Neoantigen Cancer Vaccines

Completed
  • Non Small Cell Lung Cancer
  • +4 more
  • Blood collection for research (next-generation sequencing [NGS])
  • Blood collection for research (HLA typing)
  • Chicago, Illinois
  • +4 more
Sep 10, 2020

Non Small Cell Lung Cancer Trial in United States (LN-145, Durvalumab)

Withdrawn
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +7 more
Apr 11, 2019

Non Small Cell Lung Cancer Trial in United States (BKM120 and Erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • BKM120 and Erlotinib
  • Fort Myers, Florida
  • +6 more
Feb 25, 2019

NSCLC, Non Small Cell Lung Cancer Trial in Worldwide (OSI-906, Erlotinib, Placebo)

Completed
  • NSCLC
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +28 more
Jan 21, 2019

Lung Cancer, Non Small Cell Lung Cancer Trial in United States (vandetanib induction, Docetaxel, Carboplatin)

Completed
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • vandetanib induction
  • +4 more
  • Boca Raton, Florida
  • +29 more
Apr 30, 2018

Non Small Cell Lung Cancer Trial in United States (Perifosine)

Completed
  • Non Small Cell Lung Cancer
  • Tucson, Arizona
  • +20 more
Feb 20, 2018

Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Berkeley, California
  • +152 more
Jan 24, 2018

Non Small Cell Lung Cancer, Lung Cancer Trial in United States (defactinib (VS-6063))

Completed
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • defactinib (VS-6063)
  • Denver, Colorado
  • +8 more
Apr 12, 2017

Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer Trial in Italy, Spain, United States (MSC1936369B

Completed
  • Locally Advanced Solid Tumor
  • +5 more
  • MSC1936369B (pimasertib)
  • SAR245409 (PI3K and mTOR inhibitor)
  • Scottsdale, Arizona
  • +7 more
Jan 17, 2017

Non Small Cell Lung Cancer Trial in United States (Pemetrexed, Carboplatin)

Completed
  • Non Small Cell Lung Cancer
  • Fort Myers, Florida
  • +11 more
Jan 5, 2017

Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Etoposide)

Completed
  • Non Small Cell Lung Cancer
  • Birmingham, Alabama
  • +132 more
May 20, 2016

Non Small Cell Lung Cancer Patients Treated With Erlotinib Six

Completed
  • Non Small Cell Lung Cancer
    • Nashville, Tennessee
      Tennessee Oncology, PLLC
    Mar 4, 2016

    Non Small Cell Lung Cancer Trial in United States (Pazopanib, Erlotinib)

    Completed
    • Non Small Cell Lung Cancer
    • Fort Myers, Florida
    • +7 more
    Dec 22, 2015

    Non Small Cell Lung Cancer Trial in United States (Pemetrexed, Bevacizumab, Carboplatin)

    Completed
    • Non Small Cell Lung Cancer
    • Scottsdale, Arizona
    • +26 more
    May 12, 2015

    Non Small Cell Lung Cancer Trial in Worldwide (eribulin mesylate, pemetrexed, Eribulin mesylate (eribulin; E7389))

    Unknown status
    • Non Small Cell Lung Cancer
    • eribulin mesylate
    • +2 more
    • Tucson, Arizona
    • +17 more
    Jan 23, 2015

    Non Small Cell Lung Cancer Trial in United States (STA 9090)

    Completed
    • Non Small Cell Lung Cancer
    • STA 9090
    • Tucson, Arizona
    • +20 more
    Sep 18, 2014

    Non Small Cell Lung Cancer Trial in Worldwide (IPI 504 plus Docetaxel, Placebo plus Docetaxel)

    Completed
    • Non Small Cell Lung Cancer
    • IPI 504 plus Docetaxel
    • Placebo plus Docetaxel
    • Chandler, Arizona
    • +65 more
    May 16, 2014

    Non Small Cell Lung Cancer Trial in Worldwide (Mapatumumab, Paclitaxel, Carboplatin)

    Completed
    • Non Small Cell Lung Cancer
    • Mapatumumab
    • +2 more
    • Birmingham, Alabama
    • +32 more
    Aug 1, 2013

    Non Small Cell Lung Cancer Trial in United States (Talactoferrin, Placebo)

    Unknown status
    • Non Small Cell Lung Cancer
    • Duarte, California
    • +5 more
    Mar 13, 2012